SuRo Capital (SSSS)
NASDAQ:SSSS
Top Page
SuRo Capital
(NASDAQ:SSSS)
Select Model
Select Model
Rating:64Neutral
Price Target:
$12.00
▲(0.76% Upside)
Action:ReiteratedDate:04/08/26
The score is capped by volatile profitability and inconsistent cash flow despite moderate leverage. Offsetting this are strong technical momentum, attractive valuation metrics (low P/E and high yield), and a constructive outlook from the latest call and subsequent corporate update pointing to meaningful NAV upside and lower costs, tempered by concentration and realization/timing risks.
Positive Factors
Strong liquidity and capital return flexibility
A liquid cash balance (~$49M) combined with sizable repurchase authority and note‑repurchase capacity gives SuRo durable financial flexibility to fund follow‑on investments, opportunistic buys, and support NAV through buybacks without needing immediate asset sales, supporting multi‑month execution of strategy.
Negative Factors
Portfolio concentration risk
Heavy concentration (top‑5/top‑10 representing a majority of fair value) increases exposure to individual company and sector outcomes. This structural positioning amplifies idiosyncratic volatility and makes NAV and cash generation heavily dependent on a few outcomes over the coming months, limiting diversification resilience.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong liquidity and capital return flexibility
A liquid cash balance (~$49M) combined with sizable repurchase authority and note‑repurchase capacity gives SuRo durable financial flexibility to fund follow‑on investments, opportunistic buys, and support NAV through buybacks without needing immediate asset sales, supporting multi‑month execution of strategy.
Read all positive factors
SuRo Capital (SSSS) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$302.37M
Dividend Yield5.39%
Average Volume (3M)210.28K
Price to Earnings (P/E)―
Beta (1Y)1.17
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees10
SectorFinancial
Sector Strength70
IndustryAsset Management
Share Statistics
EPS (TTM)-0.79
Shares Outstanding25,387,756
10 Day Avg. Volume258,576
30 Day Avg. Volume210,284
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)<0.01
Price to Sales (P/S)6.55
P/FCF Ratio<0.01
Enterprise Value/Market Cap-49.29K
Enterprise Value/Revenue-1.09M
Enterprise Value/Gross Profit-176.40K
Enterprise Value/Ebitda-277.48K
Forecast
1Y Price Target
$15.67Price Target Upside31.57% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.67
Revenue Forecast (FY)$1.84M
SuRo Capital Business Overview & Revenue Model
Company Description
SuRo Capital Corp. is a business development company. The firm seeks to invest in growing, late stage, venture capital-backed private companies. SuRo Capital Corp. was founded in 2010 and is based in San Francisco, California....
How the Company Makes Money
SuRo Capital makes money primarily through investment returns rather than operating revenue. Its main economic drivers are: (1) Realized gains on investments: when the company sells portfolio holdings (including following an IPO, direct listing, M...
SuRo Capital Earnings Call Summary
Earnings Call Date:Mar 09, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 12, 2026
Earnings Call Sentiment Positive
The call presented multiple strong positive items: meaningful year‑over‑year NAV growth (~21%), a large increase in share price (>60%) with total shareholder return ~70%, substantial potential NAV upside from early‑2026 financings ($5.00–$6.50 per share estimated), a sizeable cash balance (~$49M) and active capital return programs. Offsetting these positives were a quarter‑over‑quarter NAV decline (Q3 to Q4 ~12.4%), portfolio concentration (~top 10 = 80%), some locked public positions (~$17.8M), and dependence on realized gains for income. On balance the positive developments — particularly the realized strong performance in 2025 and the material prospective accretion to NAV from early‑2026 financings — outweigh the near‑term risks and lowlights.Positive Updates
Strong Share Price Performance in 2025
SuRo's stock increased from $5.88 at the start of the year to $9.44 at year-end 2025, a gain of over 60%. Including $0.50 per share of dividends declared and paid during the year, total shareholder return for 2025 approximated 70%.
Negative Updates
Quarter‑over‑Quarter NAV Decline
NAV per share fell from $9.23 at the end of Q3 2025 to $8.09 at 12/31/2025, a decline of $1.14 per share (approximately 12.4%). Management attributed the decrease to net unrealized depreciation (~$0.84 per share), dividends (~$0.25), net investment loss (~$0.22) and stock‑based compensation (~$0.10), partially offset by realized gains (~$0.27).
Read all updates
Q4-2025 Updates
Positive
Negative
Strong Share Price Performance in 2025
SuRo's stock increased from $5.88 at the start of the year to $9.44 at year-end 2025, a gain of over 60%. Including $0.50 per share of dividends declared and paid during the year, total shareholder return for 2025 approximated 70%.
Read all positive updates
Company Guidance
Management's near‑term guidance centered on financings in early 2026 that they estimate could add at least $5.00 and as much as $6.50 per share to SuRo's current NAV, with management expecting those financings to close by the end of Q1 2026 (many may not be immediately announced) and promising full context in the Q1 pre‑release/earnings call; for reference SuRo's reported year‑end NAV was $205.3M or $8.09 per share (up from $6.68 at 12/31/24, ~21% Y/Y; dividend‑adjusted NAV $8.59, ~29% Y/Y), the stock rose from $5.88 to $9.44 in 2025 (>60%) yielding ~70% total shareholder return including $0.50 of dividends, liquidity was ~$50.1M (≈$49M cash + $1.1M unrestricted public securities; ~$17.8M still locked up), top‑5 holdings were ~54% of the portfolio (top‑10 ~80%) with AI infrastructure ~31% allocation, the company committed up to $20M to TensorWave ( $5M funded as of 3/10), ATM capacity remaining ≈$87.9M, Board authorized $64.3M of share repurchases ($25M remaining), note repurchases totaled ~1,566,807 notes (~$39.2M principal, ~52% of original issuance) with ~$35.8M repurchase capacity left, and the 6.5% note conversion price was adjusted to $7.32 with 25,377,756 shares outstanding.SuRo Capital Financial Statement Overview
Summary
Income Statement
36
Negative
Balance Sheet
62
Positive
Cash Flow
46
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 34.89M | 4.67M | 6.60M | 3.46M | 1.47M |
| Gross Profit | 34.89M | -24.34M | 20.25M | -118.86M | 157.78M |
| EBITDA | 53.71M | -38.12M | 5.07M | -132.18M | 147.07M |
| Net Income | 48.81M | -38.12M | 5.07M | -132.18M | 147.07M |
Balance Sheet | |||||
| Total Assets | 10.00T> | 231.60M | 277.60M | 284.41M | 462.32M |
| Cash, Cash Equivalents and Short-Term Investments | 49.03T | 20.04M | 28.18M | 40.12M | 198.44M |
| Total Debt | 34.13T | 73.25M | 73.75M | 73.39M | 73.03M |
| Total Liabilities | 70.70T | 74.03M | 74.24M | 74.39M | 97.47M |
| Stockholders Equity | 10.00T> | 157.57M | 203.36M | 210.02M | 364.85M |
Cash Flow | |||||
| Free Cash Flow | 34.32T | 2.37M | -10.35M | -11.84M | -142.06M |
| Operating Cash Flow | 34.32T | 2.37M | -10.35M | -11.84M | -142.06M |
| Investing Cash Flow | 49.25M | 0.00 | 12.73M | -98.72M | 325.71M |
| Financing Cash Flow | -5.28T | -10.51M | -14.32M | -47.76M | -31.01M |
SuRo Capital Technical Analysis
Positive
11.91
Price Trends
9.90
Positive
9.64
Positive
9.13
Positive
Market Momentum
0.64
Negative
61.73
Neutral
82.97
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SSSS, the sentiment is Positive. The current price of 11.91 is above the 20-day moving average (MA) of 10.64, above the 50-day MA of 9.90, and above the 200-day MA of 9.13, indicating a bullish trend. The MACD of 0.64 indicates Negative momentum. The RSI at 61.73 is Neutral, neither overbought nor oversold. The STOCH value of 82.97 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SSSS.
SuRo Capital Risk Analysis
SuRo Capital disclosed 72 risk factors in its most recent earnings report. SuRo Capital reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
SuRo Capital Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $210.63M | 7.08 | 0.04% | 13.03% | 315.14% | 116.85% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | $302.37M | -2.84 | ― | 5.39% | ― | ― | |
63 Neutral | $168.09M | 11.23 | 5.30% | 21.24% | -55.82% | -4.97% | |
59 Neutral | $105.73M | -13.03 | -2.90% | 14.03% | -34.92% | -132.22% | |
52 Neutral | $207.31M | 8.14 | 14.02% | 17.28% | 206.13% | 298.86% |
* Financial Sector Average
SSSS
SuRo Capital
11.91
7.59
175.57%
WHF
WhiteHorse
7.56
-0.28
-3.60%
TPVG
TriplePoint Venture Growth
5.12
0.04
0.75%
MRCC
Monroe Capital
4.88
-1.50
-23.45%
NXDT
NexPoint Diversified Real Estate Trust
4.44
1.48
49.95%
LIEN
Chicago Atlantic BDC
9.23
-0.07
-0.71%
SuRo Capital Corporate Events
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
SuRo Capital Plans Shift to Externally Managed Structure
Positive
Apr 7, 2026
On April 2, 2026, SuRo Capital’s board unanimously approved a plan to shift from an internally managed BDC to an externally managed structure via a new advisory agreement with Neostellar Advisors LLC, a joint venture between certain SuRo emp...
Business Operations and StrategyDividendsFinancial DisclosuresPrivate Placements and Financing
SuRo Capital Expands AI Infrastructure Investment With TensorWave
Positive
Jan 12, 2026
In 2025, SuRo Capital reported that its portfolio comprised 35 companies, heavily weighted toward privately held, high‑growth businesses, with performance driven by growing recognition of the value of its investments in artificial intelligen...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.